** Shares of pathogen elimination technology company Molekule Group down 7.9% at $1.64
** Company reports Q2 loss of 76 cents per share vs 37 cents per share loss a year ago
** MKUL sees revenue for second half of 2023 at $28.5 mln-$33.5 mln
** Shares down ~50% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.